loading...
Del.icio.us
Google
Yahoo MyWeb
Facebook
Proteus Biomedical Overview
Proteus Biomedical applies its state-of-the-art semiconductor technology to the treatment of cardiovascular disease. The Company's clinical focus is on the management of congestive heart failure (CHF), a debilitating condition resulting from progressive weakening of the heart's pumping ability.
Key People
Management
- Todd Thompson, VP Product Development
- Mark Zdeblick, CTO
- Angela Strand, Sr. Director of Marketing
- George Savage, Chief Medical Officer
- Larry Arne, Director of Electronics
- Joy Berberich, Director of Finance & Administration
- David O'Reilly, SVP Corporate Development
- Andrew Thompson, CEO
- Ben Costello, VP Sensor Development
- Kathleen MCCowin, Patent Counsel & Intellectual Property Manager
Board of Directors
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 05/04/2006 | Series B | 32.7M | Unknown |
Products
No product information added yet. Add product information.
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
Profile
OpinionsUser Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Overall, are you bullish or bearish on Proteus Biomedical?
0 votes
0 votes
Vote to see results or
Web Metrics
View All Web Metrics »
| Alexa Rank: | 5026083 |  |
3437228 |
| Yahoo Search Results: | 3,810 | ||
News & Blogs
View All News »- Latest
- Most Popular
- Submit a Story »
Proteus Biomedical Raises $32M
Oct 15, 2008 - 0 comments
Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.